These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28662915)

  • 21. The spectrum of SLC17A5-gene mutations resulting in free sialic acid-storage diseases indicates some genotype-phenotype correlation.
    Aula N; Salomäki P; Timonen R; Verheijen F; Mancini G; Månsson JE; Aula P; Peltonen L
    Am J Hum Genet; 2000 Oct; 67(4):832-40. PubMed ID: 10947946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new gene, encoding an anion transporter, is mutated in sialic acid storage diseases.
    Verheijen FW; Verbeek E; Aula N; Beerens CE; Havelaar AC; Joosse M; Peltonen L; Aula P; Galjaard H; van der Spek PJ; Mancini GM
    Nat Genet; 1999 Dec; 23(4):462-5. PubMed ID: 10581036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic spectrum of Salla disease, a free sialic acid storage disorder.
    Varho TT; Alajoki LE; Posti KM; Korhonen TT; Renlund MG; Nyman SR; Sillanpää ML; Aula PP
    Pediatr Neurol; 2002 Apr; 26(4):267-73. PubMed ID: 11992753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Progressive leukoencephalopathy impairs neurobehavioral development in sialin-deficient mice.
    Stroobants S; Van Acker NG; Verheijen FW; Goris I; Daneels GF; Schot R; Verbeek E; Knaapen MW; De Bondt A; Göhlmann HW; Crauwels ML; Mancini GM; Andries LJ; Moechars DW; D'Hooge R
    Exp Neurol; 2017 May; 291():106-119. PubMed ID: 28189729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple neuroendocrine disorder in Salla disease.
    Grosso S; Berardi R; Farnetani MA; Margollicci M; Mancini MG; Morgese G; Balestri P
    J Child Neurol; 2001 Oct; 16(10):775-7. PubMed ID: 11669356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unraveling the molecular pathogenesis of free sialic acid storage disorders: altered targeting of mutant sialin.
    Aula N; Jalanko A; Aula P; Peltonen L
    Mol Genet Metab; 2002; 77(1-2):99-107. PubMed ID: 12359136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The early detection of Salla disease through second-tier tests in newborn screening: how to face incidental findings.
    Couce ML; Macías-Vidal J; Castiñeiras DE; Bóveda MD; Fraga JM; Fernández-Marmiesse A; Coll MJ
    Eur J Med Genet; 2014 Sep; 57(9):527-31. PubMed ID: 24993898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional characterization of vesicular excitatory amino acid transport by human sialin.
    Miyaji T; Omote H; Moriyama Y
    J Neurochem; 2011 Oct; 119(1):1-5. PubMed ID: 21781115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salla disease and ISSD--what does the future hold?
    Strehle EM
    Mol Genet Metab; 2004 Jun; 82(2):99-100. PubMed ID: 15171996
    [No Abstract]   [Full Text] [Related]  

  • 30. Molecular pathogenesis of sialic acid storage diseases: insight gained from four missense mutations and a putative polymorphism of human sialin.
    Ruivo R; Sharifi A; Boubekeur S; Morin P; Anne C; Debacker C; Graziano JC; Sagné C; Gasnier B
    Biol Cell; 2008 Sep; 100(9):551-9. PubMed ID: 18399798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and molecular analyses of infantile sialic acid storage disease in a patient with nonimmune hydrops fetalis.
    Kang E; Kim YM; Heo SH; Jung E; Kim KS; Yoo HJ; Kim EN; Kim CJ; Kim GH; Lee BH
    Clin Chim Acta; 2018 Jul; 482():199-202. PubMed ID: 29654786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional characterization of wild-type and mutant human sialin.
    Morin P; Sagné C; Gasnier B
    EMBO J; 2004 Nov; 23(23):4560-70. PubMed ID: 15510212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Varied mechanisms underlie the free sialic acid storage disorders.
    Wreden CC; Wlizla M; Reimer RJ
    J Biol Chem; 2005 Jan; 280(2):1408-16. PubMed ID: 15516337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal screening of sialic acid storage disease and confirmation in cultured fibroblasts by LC-MS/MS.
    van den Bosch J; Oemardien LF; Srebniak MI; Piraud M; Huijmans JG; Verheijen FW; Ruijter GJ
    J Inherit Metab Dis; 2011 Oct; 34(5):1069-73. PubMed ID: 21617927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sialic acid storage disease and related disorders.
    Strehle EM
    Genet Test; 2003; 7(2):113-21. PubMed ID: 12885332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Salla disease].
    Christensen PS; Kaad PH; Ostergaard JR
    Ugeskr Laeger; 2005 May; 167(21):2270-1. PubMed ID: 15962852
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical, biochemical, and cytochemical studies on a Japanese Salla disease case associated with a renal disorder.
    Ishiwari K; Kotani M; Suzuki M; Pumbo E; Suzuki A; Kobayashi T; Ueno T; Fukushige T; Kanzaki T; Imada M; Itoh K; Akioka S; Tajima Y; Sakuraba H
    J Hum Genet; 2004; 49(12):656-663. PubMed ID: 15635485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Free sialic acid storage (Salla) disease in Sweden.
    Erikson A; Aula N; Aula P; Månsson JE
    Acta Paediatr; 2002; 91(12):1324-7. PubMed ID: 12578289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Salla disease in Danish children. The first two cases of Salla disease in Danish children].
    Christensen PS; Kaad PH; Ostergaard JR
    Ugeskr Laeger; 2005 May; 167(21):2292-3. PubMed ID: 15962859
    [No Abstract]   [Full Text] [Related]  

  • 40. The spectrum of free neuraminic acid storage disease in childhood: clinical, morphological and biochemical observations in three non-Finnish patients.
    Sewell AC; Poets CF; Degen I; Stöss H; Pontz BF
    Am J Med Genet; 1996 May; 63(1):203-8. PubMed ID: 8723111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.